首页 > 最新文献

Revista espanola de cardiologia最新文献

英文 中文
Pregnancy in women with dilated cardiomyopathy genetic variants. 患有扩张型心肌病基因变异的妇女的怀孕问题。
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.rec.2024.04.002
M. A. Restrepo-Córdoba, P. Chmielewski, G. Truszkowska, M. L. Peña-Peña, M. Kubanek, Alice Krebsová, Luis R Lopes, Álvaro García-Ropero, M. Merlo, A. Paldino, Stacey Peters, R. Jurcut, R. Barriales-Villa, E. Zorio, M. Hazebroek, Jens Mogensen, P. García-Pavía
{"title":"Pregnancy in women with dilated cardiomyopathy genetic variants.","authors":"M. A. Restrepo-Córdoba, P. Chmielewski, G. Truszkowska, M. L. Peña-Peña, M. Kubanek, Alice Krebsová, Luis R Lopes, Álvaro García-Ropero, M. Merlo, A. Paldino, Stacey Peters, R. Jurcut, R. Barriales-Villa, E. Zorio, M. Hazebroek, Jens Mogensen, P. García-Pavía","doi":"10.1016/j.rec.2024.04.002","DOIUrl":"https://doi.org/10.1016/j.rec.2024.04.002","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"6 7","pages":""},"PeriodicalIF":5.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140755547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to Life's Essential 8 is associated with delayed biological aging: a population-based cross-sectional study. 坚持 "人生必修 8 "与生物衰老延迟有关:一项基于人群的横断面研究。
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.rec.2024.04.004
Hongyu Chen, H. Tang, Xuan Zhang, Jingtao Huang, Nan Luo, Qingqian Guo, Xin Wang
{"title":"Adherence to Life's Essential 8 is associated with delayed biological aging: a population-based cross-sectional study.","authors":"Hongyu Chen, H. Tang, Xuan Zhang, Jingtao Huang, Nan Luo, Qingqian Guo, Xin Wang","doi":"10.1016/j.rec.2024.04.004","DOIUrl":"https://doi.org/10.1016/j.rec.2024.04.004","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"87 ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140783330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesidad en España: un libro abierto que debemos leer 西班牙的肥胖症:一本值得一读的开放之书
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-28 DOI: 10.1016/j.recesp.2024.03.010
{"title":"Obesidad en España: un libro abierto que debemos leer","authors":"","doi":"10.1016/j.recesp.2024.03.010","DOIUrl":"10.1016/j.recesp.2024.03.010","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 10","pages":"Pages 819-820"},"PeriodicalIF":5.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140403772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cirugía cardiovascular y cardiología, situación actual en España de las dos especialidades hermanas: el estudio CARDIOXCARDIO 心血管外科和心脏病学,这两个姊妹专业在西班牙的现状:CARDIOXCARDIO 研究。
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-26 DOI: 10.1016/j.recesp.2024.03.012

In recent years, there has been a notable shift in cardiovascular clinical practice within cardiology and surgery. The CARDIOXCARDIO study aimed to identify professionals’ opinions on working practices and relations between specialties. A survey was simultaneously sent to the 4442 members of the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE) and the Spanish Society of Cardiology (SEC), yielding 385 valid responses. More than half (59%) of respondents were men, mostly specialists (7.3% residents), and 74.8% worked in the field of cardiology, predominantly in public centers (88.3%). Using a Likert scale ranging from 1 to 5 (worst to best), respondents rated relations between surgery and cardiology with an average of 3.57 ± 0.9 points. Cardiologists rated surgeons with a mean score of 3.83 ± 0.8, while surgeons gave cardiologists a mean score of 3,92 ± 0.72. In addition, respondents provided numerous suggestions for improvement, which are discussed in detail, highlighting certain discrepancies in criteria between specialties. Implementing strategies based on the suggestions of professionals, together with a proactive approach to continuous improvement, could substantially enhance the quality of cardiovascular care in Spain.

近年来,心血管内科和外科的临床实践发生了显著变化。CARDIOXCARDIO 研究旨在了解专业人员对工作实践和专科之间关系的看法。我们同时向西班牙心血管和血管内外科学会(SECCE)和西班牙心脏病学会(SEC)的 4442 名会员发出了调查问卷,共收到 385 份有效回复。超过半数(59%)的受访者为男性,大部分为专科医生(7.3% 为住院医师),74.8% 的受访者在心脏病学领域工作,主要在公立中心工作(88.3%)。受访者使用 1 到 5 分(从最差到最好)的李克特量表对外科和心脏病学之间的关系进行评分,平均分为 3.57 ± 0.9 分。心脏病专家给外科医生的平均评分为 3.83 ± 0.8 分,而外科医生给心脏病专家的平均评分为 3,92 ± 0.72 分。此外,受访者还提出了许多改进建议,我们将对这些建议进行详细讨论,并强调各专科在标准上的某些差异。根据专业人士的建议实施相应的策略,同时积极主动地进行持续改进,可以大大提高西班牙心血管病治疗的质量。
{"title":"Cirugía cardiovascular y cardiología, situación actual en España de las dos especialidades hermanas: el estudio CARDIOXCARDIO","authors":"","doi":"10.1016/j.recesp.2024.03.012","DOIUrl":"10.1016/j.recesp.2024.03.012","url":null,"abstract":"<div><p>In recent years, there has been a notable shift in cardiovascular clinical practice within cardiology and surgery. The CARDIOXCARDIO study aimed to identify professionals’ opinions on working practices and relations between specialties. A survey was simultaneously sent to the 4442 members of the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE) and the Spanish Society of Cardiology (SEC), yielding 385 valid responses. More than half (59%) of respondents were men, mostly specialists (7.3% residents), and 74.8% worked in the field of cardiology, predominantly in public centers (88.3%). Using a Likert scale ranging from 1 to 5 (worst to best), respondents rated relations between surgery and cardiology with an average of 3.57<!--> <!-->±<!--> <!-->0.9 points. Cardiologists rated surgeons with a mean score of 3.83<!--> <!-->±<!--> <!-->0.8, while surgeons gave cardiologists a mean score of 3,92<!--> <!-->±<!--> <!-->0.72. In addition, respondents provided numerous suggestions for improvement, which are discussed in detail, highlighting certain discrepancies in criteria between specialties. Implementing strategies based on the suggestions of professionals, together with a proactive approach to continuous improvement, could substantially enhance the quality of cardiovascular care in Spain.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 9","pages":"Pages 759-766"},"PeriodicalIF":5.9,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0300893224001192/pdfft?md5=80f5fa27ca5937ddb43f37637f419262&pid=1-s2.0-S0300893224001192-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inteligencia artificial y lenguaje médico (y IV) 人工智能和医学语言(及 IV)
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-26 DOI: 10.1016/j.recesp.2023.10.014
{"title":"Inteligencia artificial y lenguaje médico (y IV)","authors":"","doi":"10.1016/j.recesp.2023.10.014","DOIUrl":"https://doi.org/10.1016/j.recesp.2023.10.014","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 4","pages":"Pages 279-280"},"PeriodicalIF":5.9,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140296362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Una causa infrecuente de miocardiopatía hipertrófica 肥厚型心肌病的罕见病因
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-23 DOI: 10.1016/j.recesp.2024.02.003
{"title":"Una causa infrecuente de miocardiopatía hipertrófica","authors":"","doi":"10.1016/j.recesp.2024.02.003","DOIUrl":"10.1016/j.recesp.2024.02.003","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 9","pages":"Page 799"},"PeriodicalIF":5.9,"publicationDate":"2024-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novedades en la endocarditis infecciosa 感染性心内膜炎有哪些新进展?
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-22 DOI: 10.1016/j.recesp.2024.03.011

Infective endocarditis is a continually evolving disease. Present-day patients differ significantly from those treated a few decades ago: they tend to be older and have more comorbidities and health care-related episodes, while new groups of patients have emerged with new types of endocarditis, such as those affecting patients with percutaneous valve prostheses. There have also been changes in diagnostic techniques. Although transthoracic and transesophageal echocardiography are still the most commonly used imaging modalities, other techniques, such as 3-dimensional transesophageal ultrasound, cardiac computed tomography, and nuclear medicine tests (PET/CT and SPECT/CT), are increasingly used for diagnosing both the disease and its complications. In recent years, there have also been significant developments in antibiotic therapy. Currently, several treatment strategies are available to shorten the hospital phase of the disease in selected patients, which can reduce the complications associated with hospitalization, improve the quality of life of patients and their families, and reduce the health care costs of the disease. This review discusses the main recent epidemiological, diagnostic and therapeutic developments in infective endocarditis.

感染性心内膜炎是一种不断发展的疾病。现在的患者与几十年前的患者有很大不同:他们往往年龄较大,合并症和与医疗相关的发作较多,同时出现了新的心内膜炎患者群体,如使用经皮人工瓣膜的患者。诊断技术也发生了变化。虽然经胸和经食道超声心动图仍是最常用的成像方式,但其他技术,如三维经食道超声、心脏计算机断层扫描和核医学检查(PET/CT 和 SPECT/CT),正越来越多地用于诊断疾病及其并发症。近年来,抗生素治疗也取得了重大进展。目前,有几种治疗策略可用于缩短特定患者的住院期,从而减少与住院相关的并发症,提高患者及其家属的生活质量,并降低该疾病的医疗费用。本综述讨论了感染性心内膜炎在流行病学、诊断和治疗方面的主要最新进展。
{"title":"Novedades en la endocarditis infecciosa","authors":"","doi":"10.1016/j.recesp.2024.03.011","DOIUrl":"10.1016/j.recesp.2024.03.011","url":null,"abstract":"<div><p>Infective endocarditis is a continually evolving disease. Present-day patients differ significantly from those treated a few decades ago: they tend to be older and have more comorbidities and health care-related episodes, while new groups of patients have emerged with new types of endocarditis, such as those affecting patients with percutaneous valve prostheses. There have also been changes in diagnostic techniques. Although transthoracic and transesophageal echocardiography are still the most commonly used imaging modalities, other techniques, such as 3-dimensional transesophageal ultrasound, cardiac computed tomography, and nuclear medicine tests (PET/CT and SPECT/CT), are increasingly used for diagnosing both the disease and its complications. In recent years, there have also been significant developments in antibiotic therapy. Currently, several treatment strategies are available to shorten the hospital phase of the disease in selected patients, which can reduce the complications associated with hospitalization, improve the quality of life of patients and their families, and reduce the health care costs of the disease. This review discusses the main recent epidemiological, diagnostic and therapeutic developments in infective endocarditis.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 9","pages":"Pages 779-787"},"PeriodicalIF":5.9,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eventos hemorrágicos tardíos en pacientes de TAVI anticoagulados con antagonistas de la vitamina K o anticoagulantes orales de acción directa 使用维生素 K 拮抗剂或直接作用口服抗凝剂抗凝的 TAVI 患者的晚期出血事件
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-22 DOI: 10.1016/j.recesp.2024.03.008
Alberto Alperi , Raul Ptaszynski , Isaac Pascual , Raquel del Valle , Daniel Hernández-Vaquero , Marcel Almendárez , Paula Antuna , Raúl Ludeña , César Morís , Pablo Avanzas

Introduction and objectives

The optimal chronic antithrombotic regimen for patients with atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI) remains uncertain. Our aim was to compare the incidence of late bleeding events between patients on direct oral anticoagulants (DOACs) and those on vitamin-K antagonists (VKA).

Methods

This single-center observational study included TAVI patients requiring oral anticoagulation at discharge between 2015 and 2021. The primary endpoint was any clinically significant bleeding event. Secondary endpoints were stroke, heart failure, and all-cause mortality.

Results

A total of 702 TAVI procedures were performed, with 297 patients requiring oral anticoagulation at discharge. Among them, 206 (69.4%) received VKA and 91 (30.6%) received DOAC. Baseline clinical, procedural and in-hospital characteristics did not significantly differ between groups, except for better renal function among DOAC patients. The median length of follow-up was 2.8 years. The risk of bleeding events was higher in patients receiving DOACs than in those receiving VKA (HR, 2.27; 95%CI, 1.21-4.26; incidence of 9.7 and 4.2 events per 100 patient-years of follow-up for DOAC and VKA patients, respectively). There were no statistically significant differences in the rates of stroke (HR, 1.28; 95%CI, 0.4-4.3), heart failure hospitalization (HR, 0.92; 95%CI, 0.46-1.86), or all-cause mortality (HR, 1.02; 95%CI, 0.68-1.55).

Conclusions

In older patients undergoing TAVI and receiving anticoagulant therapy for atrial fibrillation, the use of DOAC was associated with a higher risk of late bleeding events than VKA.
导言和目的接受经导管主动脉瓣植入术(TAVI)的心房颤动患者的最佳慢性抗血栓治疗方案仍不确定。我们的目的是比较服用直接口服抗凝药(DOACs)和服用维生素 K 拮抗剂(VKA)的患者晚期出血事件的发生率。方法这项单中心观察性研究纳入了 2015 年至 2021 年出院时需要口服抗凝药的 TAVI 患者。主要终点是任何有临床意义的出血事件。结果共进行了 702 例 TAVI 手术,297 例患者出院时需要口服抗凝药。其中,206 人(69.4%)接受了 VKA,91 人(30.6%)接受了 DOAC。除 DOAC 患者的肾功能较好外,各组患者的基线临床、手术和院内特征无明显差异。中位随访时间为2.8年。接受 DOAC 的患者发生出血事件的风险高于接受 VKA 的患者(HR,2.27;95%CI,1.21-4.26;DOAC 和 VKA 患者每 100 患者年的随访发生率分别为 9.7 和 4.2)。在中风(HR,1.28;95%CI,0.4-4.3)、心力衰竭住院率(HR,0.92;95%CI,0.46-1.86)或全因死亡率(HR,1.02;95%CI,0.68-1.55)方面无统计学差异。
{"title":"Eventos hemorrágicos tardíos en pacientes de TAVI anticoagulados con antagonistas de la vitamina K o anticoagulantes orales de acción directa","authors":"Alberto Alperi ,&nbsp;Raul Ptaszynski ,&nbsp;Isaac Pascual ,&nbsp;Raquel del Valle ,&nbsp;Daniel Hernández-Vaquero ,&nbsp;Marcel Almendárez ,&nbsp;Paula Antuna ,&nbsp;Raúl Ludeña ,&nbsp;César Morís ,&nbsp;Pablo Avanzas","doi":"10.1016/j.recesp.2024.03.008","DOIUrl":"10.1016/j.recesp.2024.03.008","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The optimal chronic antithrombotic regimen for patients with atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI) remains uncertain. Our aim was to compare the incidence of late bleeding events between patients on direct oral anticoagulants (DOACs) and those on vitamin-K antagonists (VKA).</div></div><div><h3>Methods</h3><div>This single-center observational study included TAVI patients requiring oral anticoagulation at discharge between 2015 and 2021. The primary endpoint was any clinically significant bleeding event. Secondary endpoints were stroke, heart failure, and all-cause mortality.</div></div><div><h3>Results</h3><div>A total of 702 TAVI procedures were performed, with 297 patients requiring oral anticoagulation at discharge. Among them, 206 (69.4%) received VKA and 91 (30.6%) received DOAC. Baseline clinical, procedural and in-hospital characteristics did not significantly differ between groups, except for better renal function among DOAC patients. The median length of follow-up was 2.8 years. The risk of bleeding events was higher in patients receiving DOACs than in those receiving VKA (HR, 2.27; 95%<span>C</span>I, 1.21-4.26; incidence of 9.7 and 4.2 events per 100 patient-years of follow-up for DOAC and VKA patients, respectively). There were no statistically significant differences in the rates of stroke (HR, 1.28; 95%CI, 0.4-4.3), heart failure hospitalization (HR, 0.92; 95%CI, 0.46-1.86), or all-cause mortality (HR, 1.02; 95%CI, 0.68-1.55).</div></div><div><h3>Conclusions</h3><div>In older patients undergoing TAVI and receiving anticoagulant therapy for atrial fibrillation, the use of DOAC was associated with a higher risk of late bleeding events than VKA.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 12","pages":"Pages 976-984"},"PeriodicalIF":5.9,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140269092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Análisis de la incidencia y la letalidad del infarto agudo de miocardio en la provincia de Girona durante las tres últimas décadas 过去三十年赫罗纳省急性心肌梗死发病率和致死率分析
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-21 DOI: 10.1016/j.recesp.2023.10.017
Anna Camps-Vilaró , Isaac Subirana , Roberto Elosua , Iván Palomo , Juan Sanchis , Helena Tizón-Marcos , Miguel Cainzos-Achirica , Joan Sala , Rafael Masia , Rafel Ramos , Irene R. Dégano , Jaume Marrugat

Introduction and objectives

Myocardial infarction (MI) incidence and case fatality trends are highly informative but relatively untested at the population level. The objective of this work was to estimate MI incidence and case fatality in the Girona population aged 35-74 years, and to determine their 30-year trends (1990-2019).

Methods

The REGICOR (Girona Heart Registry) monitored MI incidence and case fatality rates from 1990 to 2008. For the period 2008 to 2019, we linked discharges from Girona hospitals (n = 4 974 977) and mortality registry (n = 70 405) during this period. Our linkage algorithm selected key MI diagnostic codes and removed duplicates. Estimates from the linkage algorithm and the REGICOR registry were compared using chi-square tests for overlapping years (2008-2009). We estimated the annual percent change (APC) of standardized MI incidence and 28-day case fatality, and analyzed their trends using joinpoint regression.

Results

MI incidence and case fatality estimates were similar in the linkage algorithm and the REGICOR registry. We observed significant decreasing trends in the incidence of MI. The trend was APC, -0.96% (95% confidence interval (95%CI), –1.4 to –0.53) in women from 1990 to 2019 and –4.2% (95%CI, –5.5 to –3.0) in men from 1994 to 2019. The largest decrease in case fatality was –3.8% (95%CI, -5.1 to –2.5) from 1995 to 2003 in women and –2.4% (95%CI, –2.9 to –1.9) from 1995 to 2004 in men, mainly due to prehospital case fatality declines: -1.8% (95%CI, –2.6 to –1.1) in men and –3.2% (95%CI, –4.6 to –1.8) in women.

Conclusions

In Girona, MI incidence and case fatality decreased between 1990 and 2019. The incidence showed a slow but continuous decrease while case fatality only stabilized in the last decade, particularly in women.

导言和目标心肌梗死(MI)发病率和病死率趋势具有很强的信息量,但在人口层面却相对缺乏检验。这项工作的目的是估计赫罗纳 35-74 岁人口的心肌梗死发病率和病死率,并确定其 30 年趋势(1990-2019 年)。在 2008 年至 2019 年期间,我们将赫罗纳医院的出院病例(n = 4 974 977)与这一时期的死亡率登记(n = 70 405)联系起来。我们的连接算法选择了关键的 MI 诊断代码,并删除了重复的代码。在重叠年份(2008-2009 年),我们使用卡方检验比较了链接算法和 REGICOR 登记的估计值。我们估算了标准化 MI 发病率和 28 天病死率的年度百分比变化 (APC),并使用连接点回归分析了其趋势。我们观察到 MI 发病率呈明显下降趋势。从 1990 年到 2019 年,女性的发病率为 APC,-0.96%(95% 置信区间 (95%CI),-1.4 到 -0.53);从 1994 年到 2019 年,男性的发病率为 -4.2%(95%CI,-5.5 到 -3.0)。从 1995 年到 2003 年,女性病例死亡率的最大降幅为-3.8%(95%CI,-5.1 到-2.5),从 1995 年到 2004 年,男性病例死亡率的最大降幅为-2.4%(95%CI,-2.9 到-1.9),这主要是由于院前病例死亡率的下降:-结论在 1990 年至 2019 年期间,赫罗纳的心肌梗死发病率和病死率均有所下降。发病率呈现缓慢但持续的下降趋势,而病死率在过去十年中才趋于稳定,尤其是在女性中。
{"title":"Análisis de la incidencia y la letalidad del infarto agudo de miocardio en la provincia de Girona durante las tres últimas décadas","authors":"Anna Camps-Vilaró ,&nbsp;Isaac Subirana ,&nbsp;Roberto Elosua ,&nbsp;Iván Palomo ,&nbsp;Juan Sanchis ,&nbsp;Helena Tizón-Marcos ,&nbsp;Miguel Cainzos-Achirica ,&nbsp;Joan Sala ,&nbsp;Rafael Masia ,&nbsp;Rafel Ramos ,&nbsp;Irene R. Dégano ,&nbsp;Jaume Marrugat","doi":"10.1016/j.recesp.2023.10.017","DOIUrl":"10.1016/j.recesp.2023.10.017","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Myocardial infarction (MI) incidence and case fatality trends are highly informative but relatively untested at the population level. The objective of this work was to estimate MI incidence and case fatality in the Girona population aged 35-74 years, and to determine their 30-year trends (1990-2019).</p></div><div><h3>Methods</h3><p>The REGICOR (Girona Heart Registry) monitored MI incidence and case fatality rates from 1990 to 2008. For the period 2008 to 2019, we linked discharges from Girona hospitals (n<!--> <!-->=<!--> <!-->4 974 977) and mortality registry (n<!--> <!-->=<!--> <!-->70 405) during this period. Our linkage algorithm selected key MI diagnostic codes and removed duplicates. Estimates from the linkage algorithm and the REGICOR registry were compared using chi-square tests for overlapping years (2008-2009). We estimated the annual percent change (APC) of standardized MI incidence and 28-day case fatality, and analyzed their trends using joinpoint regression.</p></div><div><h3>Results</h3><p>MI incidence and case fatality estimates were similar in the linkage algorithm and the REGICOR registry. We observed significant decreasing trends in the incidence of MI. The trend was APC, -0.96% (95% confidence interval (95%<span>C</span>I), –1.4 to –0.53) in women from 1990 to 2019 and –4.2% (95%CI, –5.5 to –3.0) in men from 1994 to 2019. The largest decrease in case fatality was –3.8% (95%CI, -5.1 to –2.5) from 1995 to 2003 in women and –2.4% (95%CI, –2.9 to –1.9) from 1995 to 2004 in men, mainly due to prehospital case fatality declines: -1.8% (95%CI, –2.6 to –1.1) in men and –3.2% (95%CI, –4.6 to –1.8) in women.</p></div><div><h3>Conclusions</h3><p>In Girona, MI incidence and case fatality decreased between 1990 and 2019. The incidence showed a slow but continuous decrease while case fatality only stabilized in the last decade, particularly in women.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 6","pages":"Pages 450-458"},"PeriodicalIF":5.9,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diferencias regionales en la epidemiología y los resultados de la endocarditis infecciosa en España. Un estudio poblacional contemporáneo 西班牙感染性心内膜炎流行病学和治疗效果的地区差异。基于人口的当代研究
IF 5.9 2区 医学 Q2 Medicine Pub Date : 2024-03-20 DOI: 10.1016/j.recesp.2024.01.011

Introduction and objectives

Our aim was to describe the contemporary epidemiological profile of infective endocarditis (IE) in Spain, and to evaluate variations in IE incidence, characteristics, and outcomes among the different Spanish regions (autonomous communities [AC]).

Methods

We conducted a retrospective, population-based study, using data obtained from national in-patient hospital activity of all patients discharged with a diagnosis of IE from hospitals included in the Spanish National Health System, from January 2016 to December 2019. Differences in the IE profile between the 17 Spanish AC were analyzed.

Results

A total of 9008 hospitalization episodes were identified during the study period. Standardized incidence of IE was 5.77 (95%CI, 5.12-6.41) cases per 100 000 population. Regarding predisposing conditions, 26.8% of episodes occurred in prosthetic valve carriers, 36.8% had some kind of valve heart disease, and 10.6% had a cardiac implantable electronic device. Significant differences were found between AC in terms of incidence, predisposing conditions, and microbiological profile. Cardiac surgery was performed in 19.3% of episodes in the total cohort, and in 33.4% of the episodes treated in high-volume referral centers, with wide variations among AC. Overall in-hospital mortality was 27.2%. Risk-adjusted mortality rates also varied significantly among regions.

Conclusions

We found wide heterogeneity among Spanish AC in terms of incidence rates and the clinical and microbiological characteristics of IE episodes. The proportion of patients undergoing surgery was low and in-hospital mortality rates were high, with wide differences among regions. The development of regional networks with referral centers for IE could facilitate early surgery and improve outcomes.

导言和目标我们的目的是描述西班牙感染性心内膜炎(IE)的当代流行病学概况,并评估西班牙不同地区(自治区 [AC])之间 IE 发病率、特征和预后的差异。方法我们开展了一项基于人群的回顾性研究,使用的数据来自 2016 年 1 月至 2019 年 12 月期间西班牙国家卫生系统所属医院诊断出院的所有 IE 患者的全国住院活动。研究分析了西班牙 17 个 AC 之间 IE 情况的差异。IE 标准化发病率为每 10 万人 5.77 例(95%CI,5.12-6.41)。在诱发条件方面,26.8%的病例发生在人工瓣膜携带者身上,36.8%患有某种瓣膜性心脏病,10.6%有心脏植入电子装置。在发病率、诱发条件和微生物学特征方面,AC 之间存在显著差异。在整个队列中,19.3%的病例进行了心脏手术,33.4%的病例在大容量转诊中心接受了治疗,但各转诊中心之间的差异很大。总体院内死亡率为 27.2%。结论我们发现,西班牙各转诊中心在IE发病率以及临床和微生物学特征方面存在很大差异。接受手术治疗的患者比例较低,院内死亡率较高,各地区之间差异很大。建立由 IE 转诊中心组成的地区网络可促进早期手术并改善预后。
{"title":"Diferencias regionales en la epidemiología y los resultados de la endocarditis infecciosa en España. Un estudio poblacional contemporáneo","authors":"","doi":"10.1016/j.recesp.2024.01.011","DOIUrl":"10.1016/j.recesp.2024.01.011","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Our aim was to describe the contemporary epidemiological profile of infective endocarditis (IE) in Spain, and to evaluate variations in IE incidence, characteristics, and outcomes among the different Spanish regions (autonomous communities [AC]).</p></div><div><h3>Methods</h3><p>We conducted a retrospective, population-based study, using data obtained from national in-patient hospital activity of all patients discharged with a diagnosis of IE from hospitals included in the Spanish National Health System, from January 2016 to December 2019. Differences in the IE profile between the 17 Spanish AC were analyzed.</p></div><div><h3>Results</h3><p>A total of 9008 hospitalization episodes were identified during the study period. Standardized incidence of IE was 5.77 (95%CI, 5.12-6.41) cases per 100 000 population. Regarding predisposing conditions, 26.8% of episodes occurred in prosthetic valve carriers, 36.8% had some kind of valve heart disease, and 10.6% had a cardiac implantable electronic device. Significant differences were found between AC in terms of incidence, predisposing conditions, and microbiological profile. Cardiac surgery was performed in 19.3% of episodes in the total cohort, and in 33.4% of the episodes treated in high-volume referral centers, with wide variations among AC. Overall in-hospital mortality was 27.2%. Risk-adjusted mortality rates also varied significantly among regions.</p></div><div><h3>Conclusions</h3><p>We found wide heterogeneity among Spanish AC in terms of incidence rates and the clinical and microbiological characteristics of IE episodes. The proportion of patients undergoing surgery was low and in-hospital mortality rates were high, with wide differences among regions. The development of regional networks with referral centers for IE could facilitate early surgery and improve outcomes.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 9","pages":"Pages 737-746"},"PeriodicalIF":5.9,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140273664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista espanola de cardiologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1